Screening for head and neck tumors in patients with esophageal squamous cell carcinoma and vice versa: a nationwide survey among medical specialists

Background and study aims  Retrospectively, minimally 5% of patients with esophageal squamous cell carcinoma (ESCC) and 11 % with head and neck squamous cell carcinoma (HNSCC) in Western countries developed a second primary tumor (SPT). SPT screening in ESCC and HNSCC patients is not implemented rou...

Descripción completa

Detalles Bibliográficos
Autores principales: van Tilburg, Laurelle, van den Ban, Sophie A., van de Ven, Steffi E.M., Sewnaik, Aniel, Bruno, Marco J., Spaander, Manon C.W., Baatenburg de Jong, Robert J., Koch, Arjun D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473805/
https://www.ncbi.nlm.nih.gov/pubmed/36118651
http://dx.doi.org/10.1055/a-1871-8552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473805/
https://www.ncbi.nlm.nih.gov/pubmed/36118651
http://dx.doi.org/10.1055/a-1871-8552

Ejemplares similares